{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:39:21Z","timestamp":1791589161331,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41429-025-00838-3","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:20:23Z","timestamp":1749619223000},"page":"481-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Micrococcins from Peribacillus sp. KDM594; efficacy against vancomycin-resistant enterococci and drug metabolism in a silkworm model"],"prefix":"10.1038","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4845-6791","authenticated-orcid":false,"given":"Akiho","family":"Yagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1864-8273","authenticated-orcid":false,"given":"Ryuji","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"838_CR1","unstructured":"WHO Bacterial Priority Pathogens List: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. WHO; 2024."},{"key":"838_CR2","unstructured":"O\u2019Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev Antimicrob Resist. 1\u201316 2014."},{"key":"838_CR3","unstructured":"Kristich CJ, Rice LB, Arias CA. Enterococci: from commensals to leading causes of drug resistant infection. Boston, MA: Massachusetts Eye and Ear Infirmary; 2014."},{"key":"838_CR4","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1089\/mdr.2017.0147","volume":"24","author":"MO Ahmed","year":"2018","unstructured":"Ahmed MO, Baptiste KE. Vancomycin-resistant enterococci: a review of antimicrobial resistance mechanisms and perspectives of human and animal health. Microb Drug Resist. 2018;24:590\u2013606.","journal-title":"Microb Drug Resist"},{"key":"838_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ja.2010.9","volume":"63","author":"R Uchida","year":"2010","unstructured":"Uchida R, Iwatsuki M, Kim YP, Ohte S, \u014cmura S, Tomoda H. Nosokomycins, new antibiotics, discovered in an in vivo-mimic infection model using silkworm larvae. I. Fermentation, isolation and biological properties. J Antibiot. 2010;63:151\u2013155.","journal-title":"J Antibiot"},{"key":"838_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/ja.2010.10","volume":"63","author":"R Uchida","year":"2010","unstructured":"Uchida R, Iwatsuki M, Kim YP, \u014cmura S, Tomoda H. Nosokomycins, new antibiotics, discovered in an in vivo-mimic infection model using silkworm larvae. II. Structure elucidation. J Antibiot. 2010;63:157\u2013163.","journal-title":"J Antibiot"},{"key":"838_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5582\/ddt.2014.01050","volume":"8","author":"R Uchida","year":"2014","unstructured":"Uchida R, Hanaki H, Matsui H, Hamamoto H, Sekimizu K, Iwatsuki M, Kim YP, Tomoda H. In vitro and in vivo anti-MRSA activities of nosokomycins. Drug Discov Ther. 2014;8:249\u2013254.","journal-title":"Drug Discov Ther"},{"key":"838_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nchembio.1710","volume":"11","author":"H Hamamoto","year":"2015","unstructured":"Hamamoto H, Urai M, Ishii K, et al. Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane. Nat Chem Biol. 2015;11:127\u2013133.","journal-title":"Nat Chem Biol"},{"key":"838_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5582\/ddt.2016.01013","volume":"20","author":"R Uchida","year":"2016","unstructured":"Uchida R, Namiguchi S, Ishijima H, Tomoda H. Therapeutic effects of three trichothecenes in the silkworm infection assay with Candida albicans. Drug Discov Ther. 2016;20:44\u201348.","journal-title":"Drug Discov Ther"},{"key":"838_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41429-018-0049-8","volume":"71","author":"T Tominaga","year":"2018","unstructured":"Tominaga T, Uchida R, Koyama N, Tomoda H. Anti-Rhizopus activity of tanzawaic acids produced by the hot spring-derived fungus Penicillium sp. BF-0005. J Antibiot. 2018;71:626\u2013632.","journal-title":"J Antibiot"},{"key":"838_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ja.2017.23","volume":"70","author":"A Yagi","year":"2017","unstructured":"Yagi A, Uchida R, Hamamoto H, Sekimizu K, Kimura K, Tomoda H. Anti-Mycobacterium activity of microbial peptides in a silkworm infection model with Mycobacterium smegmatis. J Antibiot. 2017;70:685\u2013690.","journal-title":"J Antibiot"},{"key":"838_CR12","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.3390\/molecules25214971","volume":"25","author":"K Hosoda","year":"2020","unstructured":"Hosoda K, Koyama N, Hamamoto H, Yagi A, Uchida R, Kanamoto A, Tomoda H. Evaluation of anti-mycobacterial compounds in a silkworm infection model with Mycobacteroides abscessus. Molecules. 2020;25:4971.","journal-title":"Molecules"},{"key":"838_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5582\/ddt.2020.03099","volume":"14","author":"A Yagi","year":"2021","unstructured":"Yagi A, Yamazaki H, Terahara T, Yang T, Hamamoto H, Imada C, Tomoda H, Uchida R. Development of an in vivo-mimic silkworm infection model with Mycobacterium avium complex. Drug Discov Ther. 2021;14:287\u2013295.","journal-title":"Drug Discov Ther"},{"key":"838_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41429-024-00724-4","volume":"77","author":"A Yagi","year":"2024","unstructured":"Yagi A, Fujiwara M, Sato M, Abe Y, Uchida R. New liposidomycin congeners produced by Streptomyces sp. TMPU-20A065, anti-Mycobacterium avium complex agents with therapeutic efficacy in a silkworm infection model. J Antibiot. 2024;77:412\u2013421.","journal-title":"J Antibiot"},{"key":"838_CR15","doi-asserted-by":"publisher","unstructured":"Yagi A, Sato T, Kano C, Igari T, Oshima N, Ohte S, Ohshiro T, Uchida R. Evaluation of tirandamycins with selective activity against Enterococci in the silkworm infection model. J Antibiot. 2025 https:\/\/doi.org\/10.1038\/s41429-024-00805-4.","DOI":"10.1038\/s41429-024-00805-4"},{"key":"838_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1128\/AAC.48.3.774-779.2004","volume":"48","author":"H Hamamoto","year":"2004","unstructured":"Hamamoto H, Kurokawa K, Kaito C, Kamura K, Manitra Razanajatovo I, Kusuhara H, Santa T, Sekimizu K. Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms. Antimicrob Agents Chemother. 2004;48:774\u2013779.","journal-title":"Antimicrob Agents Chemother"},{"key":"838_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cbpc.2008.08.008","volume":"149","author":"H Hamamoto","year":"2009","unstructured":"Hamamoto H, Tonoike A, Narushima K, Horie R, Sekimizu K. Silkworm as a model animal to evaluate drug candidate toxicity and metabolism. Comp Biochem Physiol C Toxicol Pharmacol. 2009;149:334\u2013339.","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"838_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46013-1","volume":"9","author":"H Hamamoto","year":"2019","unstructured":"Hamamoto H, Horie R, Sekimizu K. Pharmacokinetics of anti-infectious reagents in silkworms. Sci Rep. 2019;9:9451.","journal-title":"Sci Rep"},{"key":"838_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1039\/c39780000256","volume":"6","author":"BW Bycroft","year":"1978","unstructured":"Bycroft BW, Gowland MS. The structures of the highly modified peptide antibiotics micrococcin P1 and P2. J Chem Soc Chem Commun. 1978;6:256\u2013258.","journal-title":"J Chem Soc Chem Commun"},{"key":"838_CR20","unstructured":"Clinical and Laboratory Standards Institute (CLSI): Reference methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard CLSI document M07-A11. 11th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2019."},{"key":"838_CR21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3390\/molecules24081495","volume":"24","author":"K Hosoda","year":"2019","unstructured":"Hosoda K, Koyama N, Kanamoto A, Tomoda H. Discovery of nosiheptide, griseoviridin, and etamycin as potent anti-mycobacterial agents against Mycobacterium avium complex. Molecules. 2019;24:1495.","journal-title":"Molecules"},{"key":"838_CR22","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.3390\/molecules25194383","volume":"25","author":"W Wang","year":"2020","unstructured":"Wang W, Park KH, Lee J, Oh E, Park C, Kang E, Lee J, Kang H. A new thiopeptide antibiotic, micrococcin P3, from a marine-derived strain of the bacterium Bacillus stratosphericus. Molecules. 2020;25:4383.","journal-title":"Molecules"},{"key":"838_CR23","doi-asserted-by":"publisher","first-page":"8259","DOI":"10.1016\/j.bmc.2006.09.006","volume":"14","author":"M Hashimoto","year":"2006","unstructured":"Hashimoto M, Murakami T, Funahashi K, Tokunaga T, Nihei K, Okuno T, Kimura T, Naoki H, Himeno H. An RNA polymerase inhibitor, cyclothiazomycin B1, and its isomer. Bioorg Med Chem. 2006;14:8259\u20138270.","journal-title":"Bioorg Med Chem"},{"key":"838_CR24","first-page":"473","volume":"29","author":"TL Su","year":"1948","unstructured":"Su TL. Micrococcin, an antibacterial substance formed by a strain of Micrococcus. Br J Exp Pathol. 1948;29:473\u2013481.","journal-title":"Br J Exp Pathol"},{"key":"838_CR25","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1002\/anie.200900621","volume":"48","author":"D Lefranc","year":"2009","unstructured":"Lefranc D, Ciufolini MA. Total synthesis and stereochemical assignment of Micrococcin P1. Angew Chem Int Ed. 2009;48:4198\u20134201.","journal-title":"Angew Chem Int Ed"},{"key":"838_CR26","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1128\/JB.00396-16","volume":"198","author":"PR Bennallack","year":"2016","unstructured":"Bennallack PR, Bewley KD, Burlingame MA, Robison RA, Miller SM, Griffitts JS. Reconstitution and minimization of a micrococcin biosynthetic pathway in Bacillus subtilis. J Bacteriol. 2016;198:2431\u20132438.","journal-title":"J Bacteriol"},{"key":"838_CR27","doi-asserted-by":"publisher","first-page":"12450","DOI":"10.1073\/pnas.1612161113","volume":"113","author":"KD Bewley","year":"2016","unstructured":"Bewley KD, Bennallack PR, Burlingame MA, Robison RA, Griffitts JS, Miller SM. Capture of micrococcin biosynthetic intermediates reveals C-terminal processing as an obligatory step for in vivo maturation. Proc Natl Acad Sci. 2016;113:12450\u201312455.","journal-title":"Proc Natl Acad Sci"},{"key":"838_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/aem.00244-24","volume":"90","author":"DG Calvopina-Chavez","year":"2024","unstructured":"Calvopina-Chavez DG, Bursey DM, Tseng Y-J, et al. Micrococcin cysteine-to-thiazole conversion through transient interactions between the scaffolding protein TclI and the modification enzymes TclJ and TclN. Appl Environ Microbiol. 2024;90:e0024424.","journal-title":"Appl Environ Microbiol"},{"key":"838_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tube.2016.07.011","volume":"100","author":"G Degiacomi","year":"2016","unstructured":"Degiacomi G, Personne Y, Mond\u00e9sert G, et al. Micrococcin P1 - a bactericidal thiopeptide active against Mycobacterium tuberculosis. Tuberculosis. 2016;100:95\u2013101.","journal-title":"Tuberculosis"},{"key":"838_CR30","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1021\/acs.jnatprod.2c00120","volume":"85","author":"YJ Son","year":"2022","unstructured":"Son YJ, Kim YR, Oh SH, Jung S, Ciufolini MA, Hwang HJ, Kwak JH, Pai H. Micrococcin P2 Targets Clostridioides difficile. J Nat Prod. 2022;85:1928\u20131935.","journal-title":"J Nat Prod"},{"key":"838_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01825-23","volume":"11","author":"J Park","year":"2023","unstructured":"Park J, Kim LH, Lee JM, Choi S, Son YJ, Hwang HJ, Shin SJ. In vitro and intracellular activities of novel thiopeptide derivatives against macrolide-susceptible and macrolide-resistant Mycobacterium avium complex. Microbiol Spectr. 2023;11:e0182523.","journal-title":"Microbiol Spectr"},{"key":"838_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106965","volume":"62","author":"R Fern\u00e1ndez-Fern\u00e1ndez","year":"2023","unstructured":"Fern\u00e1ndez-Fern\u00e1ndez R, Lozano C, Fern\u00e1ndez-P\u00e9rez R, Zarazaga M, Peschel A, Krismer B, Torres C. Detection and evaluation of the antimicrobial activity of Micrococcin P1 isolated from commensal and environmental staphylococcal isolates against MRSA. Int J Antimicrob Agents. 2023;62:106965.","journal-title":"Int J Antimicrob Agents"},{"key":"838_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/nar\/22.3.357","volume":"22","author":"G Rosendahl","year":"1994","unstructured":"Rosendahl G, Douthwaite S. The antibiotics micrococcin and thiostrepton interact directly with 23S rRNA nucleotides 1067A and 1095A. Nucleic Acids Res. 1994;22:357\u2013363.","journal-title":"Nucleic Acids Res"},{"key":"838_CR34","doi-asserted-by":"publisher","first-page":"14263","DOI":"10.1021\/acs.jmedchem.3c01309","volume":"66","author":"D Kim","year":"2023","unstructured":"Kim D, Lee J, Shyaka C, et al. Identification of Micrococcin P2-derivatives as antibiotic candidates against two gram-positive pathogens. J Med Chem. 2023;66:14263\u201314277.","journal-title":"J Med Chem"},{"key":"838_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0006-2952(95)00124-I","volume":"50","author":"H Ohara","year":"1995","unstructured":"Ohara H, Miyabe Y, Deyashiki Y, Matsuura K, Hara A. Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver. Biochem Pharmacol. 1995;50:221\u2013227.","journal-title":"Biochem Pharmacol"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00838-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00838-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00838-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:05:30Z","timestamp":1757185530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00838-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1038\/s41429-025-00838-3","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"5 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}